13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001846368
Total reported value
$7.2B
$7.2B
141 檔
76.5%
According to the latest 13F quarterly dataset, Simplify Asset Management Inc. managed an equity portfolio of $7.2B at the end of Q4 2025, spanning 141 distinct U.S. exchange-listed positions.
In Q4 2025, Simplify Asset Management Inc. displayed an active expansion posture, initiating 9 new positions and adding to 20 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SBIL | Simplify Govt Mny Mrkt ETF | ETF-Other | 71.32% | -2.27% | +31.63% | |
| 2 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 11.29% | -0.08% | +1.64% | |
| 3 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 4.57% | +0.69% | -0.09% | |
| 4 | IBIT | Ishares Bitcoin Trust ETF | ETF-Crypto | 1.31% | +0.03% | +24.03% | |
| 5 | SPUC | Simplify US Eqty Plus Up | ETF-Other | 1.24% | +0.01% | — | |
| 6 | QIS | Simplify Multi-qis Alt ETF | ETF-Other | 0.92% | -0.17% | -18.37% | |
| 7 | NMB | Simplify National Muni Bnd | ETF-Other | 0.63% | -0.04% | — | |
| 8 | AGGH | Simplify Aggregate Bond ETF | ETF-Other | 0.63% | -0.07% | -50.00% | |
| 9 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.54% | +0.23% | +239.94% | |
| 10 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.49% | +0.01% | +189.52% | |
| 11 | NXTI | Simplify Next Intg C Idx ETF | ETF-Other | 0.44% | +0.03% | — | |
| 12 | PAGP | Plains Gp Holdings Lp-cl A | Stock-Energy | 0.40% | -0.04% | — | |
| 13 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.39% | -0.13% | EXIT | |
| 14 | AMGN | Amgen Inc | Stock-Healthcare | 0.28% | +0.02% | — | |
| 15 | ALGN | Align Technology Inc | Stock-Healthcare | 0.27% | -0.12% | — | |
| 16 | PCT | Purecycle Technologies Inc | Stock-Other | 0.27% | +0.20% | +227.38% | |
| 17 | XV | Simplify Target 15 Distr ETF | ETF-Other | 0.26% | -0.01% | -35.92% | |
| 18 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 0.22% | — | +403.34% | |
| 19 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 0.20% | +0.08% | — | |
| 20 | UTHR | United Therapeutics CORP | Stock-Healthcare | 0.19% | +0.03% | +19.67% | |
| 21 | BHVN | Biohaven Ltd. | Stock-Other | 0.18% | +0.10% | +773.59% | |
| 22 | DHR | Danaher CORP | Stock-Healthcare | 0.17% | +0.02% | +449.77% | |
| 23 | WRBY | Warby Parker Inc-class A | Stock-Other | 0.14% | +0.16% | — | |
| 24 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.14% | -0.04% | +92.93% | |
| 25 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 0.13% | +0.02% | +1327.92% | |
| 26 | TXG | 10x Genomics Inc-class A | Stock-Other | 0.13% | +0.04% | — | |
| 27 | EYPT | Eyepoint Inc | Stock-Other | 0.11% | +0.02% | +314.93% | |
| 28 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 0.11% | — | +92.13% | |
| 29 | INSM | Insmed Inc | Stock-Healthcare | 0.10% | -0.01% | +87.60% | |
| 30 | ACHV | Achieve Life Sciences Inc | Stock-Other | 0.10% | +0.08% | — | |
| 31 | CVS | Cvs Health CORP | Stock-Healthcare | 0.10% | +0.04% | -12.72% | |
| 32 | TSLA | Tesla Inc | Stock-Consumer Disc | 0.09% | — | -47.28% | |
| 33 | ABBV | Abbvie Inc | Stock-Healthcare | 0.09% | +0.07% | -35.53% | |
| 34 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.09% | — | — | |
| 35 | ✓ | Establishment Labs Holdings In | Stock-Other | 0.09% | +0.02% | +92.09% | |
| 36 | ALHC | Alignment Healthcare Inc | Stock-Other | 0.08% | -0.05% | EXIT | |
| 37 | PEN | Penumbra Inc | Stock-Healthcare | 0.08% | — | +89.73% | |
| 38 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 0.08% | +0.03% | NEW | |
| 39 | HODL | Vaneck Bitcoin ETF | ETF-Crypto | 0.08% | — | -17.90% | |
| 40 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.08% | +0.01% | -37.73% | |
| 41 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.07% | +0.14% | +92.60% | |
| 42 | GEHC | GE Healthcare Technology | Stock-Healthcare | 0.07% | +0.01% | +91.70% | |
| 43 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.07% | — | -47.80% | |
| 44 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 0.06% | — | +92.59% | |
| 45 | VRDN | Viridian Therapeutics Inc | Stock-Other | 0.05% | -0.02% | EXIT | |
| 46 | XXV | Simplify Ancorato Trg 25 Dis | ETF-Other | 0.05% | — | — | |
| 47 | MIST | Milestone Pharmaceuticals In | Stock-Other | 0.05% | +0.03% | -46.83% | |
| 48 | GH | Guardant Health Inc | Stock-Healthcare | 0.05% | +0.03% | -4.88% | |
| 49 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 0.05% | — | — | |
| 50 | LITL | Simplify Ppr Sndlr US Sm Cap | ETF-Other | 0.04% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SBIL | Simplify Govt Mny Mrkt ETF | +10.2% | +31.63% | Add |
| 2 | UNH | Unitedhealth Group Inc | +0.4% | +239.94% | Add |
| 3 | LLY | Eli Lilly & Co | +0.4% | +189.52% | Add |
| 4 | REGN | Regeneron Pharmaceuticals | +0.3% | +139.99% | Add |
| 5 | APLSUSD | Apellis Pharmaceuticals Inc | +0.2% | +403.34% | Add |
| 6 | BHVN | Biohaven Ltd. | +0.2% | +773.59% | Add |
| 7 | DHR | Danaher CORP | +0.1% | +449.77% | Add |
| 8 | PCT | Purecycle Technologies Inc | +0.1% | +227.38% | Add |
| 9 | VRTX | Vertex Pharmaceuticals Inc | +0.1% | +1327.92% | Add |
| 10 | EYPT | Eyepoint Inc | +0.1% | +314.93% | Add |
| 11 | ISRG | Intuitive Surgical Inc | +0.1% | +92.93% | Add |
| 12 | ✓ | Establishment Labs Holdings In | +0.1% | +92.09% | Add |
| 13 | AZNN | Astrazeneca Plc-spons Adr | +0.1% | +92.13% | Add |
| 14 | INSM | Insmed Inc | +0.1% | +87.60% | Add |
| 15 | UTHR | United Therapeutics CORP | 0% | +19.67% | Add |
| 16 | PEN | Penumbra Inc | 0% | +89.73% | Add |
| 17 | ALHC | Alignment Healthcare Inc | 0% | +91.98% | Add |
| 18 | JNJ | Johnson & Johnson | 0% | +92.60% | Add |
| 19 | MIST | Milestone Pharmaceuticals In | -0.1% | -46.83% | Trim |
| 20 | ABVX | Abivax Sa-adr | -0.1% | -72.41% | Trim |
| 21 | HODL | Vaneck Bitcoin ETF | -0.1% | -17.90% | Trim |
| 22 | NKTR | Nektar Therapeutics | -0.1% | -67.88% | Trim |
| 23 | ABBV | Abbvie Inc | -0.1% | -35.53% | Trim |
| 24 | NBIX | Neurocrine Biosciences Inc | -0.1% | -90.71% | Trim |
| 25 | MLYS | Mineralys Therapeutics Inc | -0.1% | -47.80% | Trim |
| 26 | TSLA | Tesla Inc | -0.1% | -47.28% | Trim |
| 27 | XV | Simplify Target 15 Distr ETF | -0.2% | -35.92% | Trim |
| 28 | IBIT | Ishares Bitcoin Trust ETF | -0.3% | +24.03% | Add |
| 29 | SPUC | Simplify US Eqty Plus Up | -0.3% | — | Unchanged |
| 30 | QIS | Simplify Multi-qis Alt ETF | -0.7% | -18.37% | Trim |
| 31 | AGGH | Simplify Aggregate Bond ETF | -0.8% | -50.00% | Trim |
| 32 | IVV | Ishares Core S&p 500 ETF | -1% | +1.64% | Add |
| 33 | GLD | Spdr Gold Shares | — | EXIT | Sold out |
| 34 | AMGN | Amgen Inc | — | NEW | New buy |
| 35 | ALGN | Align Technology Inc | — | NEW | New buy |
| 36 | JAZZ | Jazz Pharmaceuticals plc | — | NEW | New buy |
| 37 | FOXY | Simplify Currency Strtgy ETF | — | EXIT | Sold out |
| 38 | WRBY | Warby Parker Inc-class A | — | NEW | New buy |
| 39 | TXG | 10x Genomics Inc-class A | — | NEW | New buy |
| 40 | SBAR | Simplify Barrier Income ETF | — | EXIT | Sold out |
| 41 | AKRO | Akero Therapeutics Inc | — | EXIT | Sold out |
| 42 | TSLL | Dirx Dly Tsla Bul 2x Etf-aui | — | EXIT | Sold out |
| 43 | ARQT | Arcutis Biotherapeutics Inc | — | EXIT | Sold out |
| 44 | EYE | National Vision Holdings Inc | — | EXIT | Sold out |
| 45 | QQQ | Invesco Qqq Trust Series 1 | — | NEW | New buy |
| 46 | XXV | Simplify Ancorato Trg 25 Dis | — | NEW | New buy |
| 47 | ✓ | Merus N V | — | EXIT | Sold out |
| 48 | OSCR | Oscar Health Inc - Class A | — | NEW | New buy |
| 49 | APLT | Applied Therapeutics Inc | — | EXIT | Sold out |
| 50 | CTAP | Simplify US Eq Plus Mgd Fut | — | NEW | New buy |
According to official SEC Form 13F filings, Simplify Asset Management Inc. reported a total U.S. public equity portfolio value of $7.2B across 141 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SBIL, IVV, AGG) accounted for 76.5% of total reported equity market value during Q4 2025.
Top New Position Initiated
AMGN
市值: $17.1M
Top Position Liquidated / Trimmed
GLD
前期市值: $451.2M
During Q4 2025, Simplify Asset Management Inc.'s top holdings by market value included SBIL (71.3%)、IVV (11.3%)、AGG (4.6%). The largest single position, SBIL, represented 71.3% of total portfolio value.
In Q4 2025, Simplify Asset Management Inc. made 49 total portfolio adjustments, initiating 9 new buys, adding to 20 positions, trimming 11 holdings, and fully liquidating 9 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.